Top

Clinical Pharmacokinetics

Published in:

01-11-2011 | Correspondence

The Authors’ Reply: Obesity and Allometric Scaling of Pharmacokinetics

Authors: Jeroen Diepstraten, Catherijne A. J. Knibbe

Published in: Clinical Pharmacokinetics | Issue 11/2011

Excerpt

We thank Eleveld et al.[1] for their commentary in relation to our article.[2] …

Eleveld DJ, Proost JH, Absalom AR, et al. Obesity and allometric scaling of pharmacokinetics. Clin Pharmacokinet 2011; 50(11): 751–3PubMedCrossRef

van Kralingen S, Diepstraten J, Peeters MYM, et al. Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients. Clin Pharmacokinet 2011; 50(11): 739–50PubMedCrossRef

Kleiber M. Energy metabolism. Annu Rev Physiol 1944; 6: 123–54CrossRef

Kolokotrones T, Van S, Deeds EJ, et al. Curvature in metabolic scaling. Nature 2010 Apr 1; 464(7289): 753–6PubMedCrossRef

White CR, Cassey P, Blackburn TM. Allometric exponents do not support a universal metabolic allometry. Ecology 2007 Feb; 88(2): 315–23PubMedCrossRef

Glazier DS. Beyond the ‘3/4-power law’: variation in the intra- and interspecific scaling of metabolic rate in animals. Biol Rev Camb Philos Soc 2005 Nov; 80(4): 611–62PubMedCrossRef

Packard GC, Birchard GF. Traditional allometric analysis fails to provide a valid predictive model for mammalian metabolic rates. J Exp Biol 2008 Nov; 211(Pt 22): 3581–7PubMedCrossRef

Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303–32PubMedCrossRef

Mahmood I. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model? Br J Clin Pharmacol 2011 Jan; 71(1): 88–94PubMedCrossRef

10.

Mahmood I. Application of fixed exponent 0.75 to the prediction of human drug clearance: an inaccurate and misleading concept. Drug Metabol Drug Interact 2009; 24(1): 57–81PubMedCrossRef

11.

Krekels EH, van Hasselt JG, Tibboel D, et al. Systematic evaluation of the descriptive and predictive performance of paediatric morphine population models. Pharm Res 2011 Apr; 28(4): 797–811PubMedCrossRef

12.

Zavorsky GS. Cardiopulmonary aspects of obesity in women. Obstet Gynecol Clin North Am 2009 Jun; 36(2): 267–84, viiiPubMedCrossRef

13.

Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005 May; 115(5): 1111–9PubMed

14.

Guzzaloni G, Grugni G, Minocci A, et al. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 2000 Jun; 24(6): 772–6PubMedCrossRef

15.

Cortínez LI, Anderson BJ, Penna A, et al. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth 2010 Oct; 105(4): 448–56PubMedCrossRef

16.

Han PY, Duffull SB, Kirkpatrick CM, et al. Dosing in obesity: a simple solution to a big problem. Clin Pharmacol Ther 2007 Nov; 82(5): 505–8PubMedCrossRef

17.

Kotlyar M, Carson SW. Effects of obesity on the cytochrome P450 enzyme system. Int J Clin Pharmacol Ther 1999 Jan; 37(1): 8–19PubMed

18.

van Kralingen S, Diepstraten J, van de Garde EM, et al. Comparative evaluation of propofol 350 and 200 mg for induction of anaesthesia in morbidly obese patients: a randomized double-blind pilot study. Eur J Anaesthesiol 2010 Jun; 27(6): 572–4PubMed

Title: The Authors’ Reply: Obesity and Allometric Scaling of Pharmacokinetics
Authors: Jeroen Diepstraten
Catherijne A. J. Knibbe
Publication date: 01-11-2011
Publisher: Springer International Publishing
Published in: Clinical Pharmacokinetics / Issue 11/2011
Print ISSN: 0312-5963
Electronic ISSN: 1179-1926
DOI: https://doi.org/10.2165/11597830-000000000-00000

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Authors’ Reply: Obesity and Allometric Scaling of Pharmacokinetics

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2011

Obesity and Allometric Scaling of Pharmacokinetics

Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients

Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole

Pharmacokinetics of Metformin in Girls Aged 9 Years

Pharmacokinetics of Antimalarials in Pregnancy

Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid